Loss of heterozygosity in 73 human thyroid tumors

Neuroendocrinology Letters

Volumn 26, Issue 5, 2005, Pages 521-525

  Wozniak, Agnieszka ^a   Wiench, Malgorzata ^b   Olejniczak, Agnieszka ^a   Wloch, Jan ^b   Lachinski, Andrzej ^a   Lange, Dariusz ^b   Olczyk, Tomasz ^b   Jarzab, Barbara ^b   Limon, Janusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

LOH; RET PTC; Thyroid tumor

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; COLLOID; DNA EXTRACTION; FEMALE; FISHER EXACT TEST; GENE FREQUENCY; GENE LOCUS; GENE REARRANGEMENT; GENETIC POLYMORPHISM; GOITER; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA; THYROID TUMOR; THYROIDECTOMY;

EID: 29544438513     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Zedenius J, Wallin G, Svensson A, Bovee J, Hoog A, Backdahl M, et al. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors. Hum Genet 1996; 97:299-303.
2. Grebe SK, McIver B, Hay ID, Wu PS, Maciel LM, Drabkin HA, et al. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab 1997; 82:3684-91.
3. Tung WS, Shevlin DW, Kaleem Z, Tribune DJ, Wells SA, Goodfellow PJ. Allelotype of follicular thyroid carcinomas reveals genetic instability consistent with frequent nondisjunctional chromosomal loss. Genes Chromosome Cancer 1997; 19:43-51.
4. Ward LS, Brenta G, Medvedovic M, Fagin JA. Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas. J Clin Endocrinol Metab 1998; 83:525-30.
5. Trovato M, Fraggetta F, Villari D, Batolo D, Mackey K, Trimarchi F, et al. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer. J Clin Endocrinol Metab 1999; 84:3235-40.
6. Yeh JJ, Marsh DJ, Zedenius J, Dwight T, Delbridge L, Robinson BG, et al. Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways. Genes Chromosome Cancer 1999; 26:322-8.
7. Kitamura Y, Shimizu K, Ito K, Tanaka S, Emi M. Allelotyping of follicular losses in chromosome arms 7q, 11p and 22q. J Clin Endocrinol Metab 2001; 86:4268-72.
8. Oriola J, Halperin I, Mallofre C, Muntane J, Angel M, Rivera-Fillat F. Screening of selected genomic areas potentially involved in thyroid neoplasms. Eur J Cancer 2001; 37:2470-4.
9. Pierotti MA. Chromosomal rearrangements in thyroid carcinomas: a recombination or death dilemma. Cancer Lett 2001; 166:1-7.
10. Gimm O. Thyroid cancer. Mini review. Cancer Letters 2001; 163:143-56.
11. Hedinger C, Williams E., Sobin L. The WHO histological classification of tumors: a commentary on the second edition. Cancer 1989; 63:908-11.
12. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after Chernobyl reactor accident. Oncogene 1995; 11:2459-67.
13. Zhang JS, Nelson M, McIver B, Hay ID, Goellner JR, Grant CS, et al. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene 1998; 17:789-93.
14. Wiench M, Wloch J, Oczko M, Gubala E, Jarzab B. Rearrangement of the RET gene in papillary thyroid carcinoma. Wiad Lek 2001; 54:64-71 (in Polish with English abstract.)
15. Bongarzone I, Fugazzola L, Vigneri P, Mariani L, Mondellini P, Pacini F, et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab 1996; 81:2006-9.
16. Bongarzone I, Vigneri P, Mariani L, Collini P, Pilotti S, Pierotti MA. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features. Clin Cancer Res 1998; 4:223-8.
17. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 2003; 95:625-27.
18. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, et al. Clinical implications of hot spot BRAF mutation, V599E, in papillar thyroid cancers. J Clin Endocrinol Metab 2003; 88:4393-7.
19. Schlumberger MJ. Diagnostic follow-up of well-differentiated thyroid carcinoma: historical perspective and current status. J Endocrinol Invest 1999; 22(11 Suppl):3-7.
20. Mazzaferri EL, Kloos RT, Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2000; 86:1447-63
21. Frisk T, Kytola S, Wallin G, Zedenius J, Larsson C. Low frequency of numerical chromosomal aberrations in follicular thyroid tumors detected by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 25:349-53.
22. Kjellman P, Lagercrantz S, Hoog A, Wallin G, Larsson C, Zedenius J. Gain of 1q and loss of 9q21.3-q32 are associated with a less favorable prognosis in papillary thyroid carcinoma. Genes Chromosomes Cancer 2001; 32:43-9.
23. Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M. Association of allelic loss on 1q, 4p, 7q, 9p, 9q and 16q with postoperative death in papillary carcinoma. Clin Cancer Res 2000; 6:1819-25.